© 2022 MJH Life Sciences and Contagion Live. All rights reserved.
© 2022 MJH Life Sciences™ and Contagion Live. All rights reserved.
December 25, 2020
Since late 2004, 7 novel antibiotics with activity against ESBL-E, CRE, and/or DTR P aeruginosa have been approved.
September's Top 5 Infectious Disease Stories
COVID-19 Vaccine Boosters: Roadblocks, the Future, and Communicating the Benefits to Patients
CDC Updates Pneumococcal Conjugate Vaccine Recommendations
Shionogi Reaches Endpoint for Phase 3 COVID-19 Pill